After scoring in a more common form of pulmonary fibrosis in May, Bristol Myers Squibb’s lysophosphatidic acid receptor 1 (LPA1) antagonist has turned out positive results in a rarer incarnation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback